Search Results

There are 37866 results for: content related to: ETHICAL PROBLEMS IN CONDUCTING RESEARCH IN ACUTE EPIDEMICS: THE PFIZER MENINGITIS STUDY IN NIGERIA AS AN ILLUSTRATION

  1. The Precautionary Principle in EC Health and Environmental Law

    European Law Journal

    Volume 12, Issue 2, March 2006, Pages: 139–172, Nicolas de Sadeleer

    Version of Record online : 9 MAR 2006, DOI: 10.1111/j.1468-0386.2006.00313.x

  2. International Legal and Ethical Considerations at Pfizer, Inc.

    Journal of Legal Studies Education

    Volume 22, Issue 2, March 2005, Pages: 169–197, Marisa Anne Pagnattaro

    Version of Record online : 1 APR 2005, DOI: 10.1111/j.1744-1722.2005.00017.x

  3. Survival of classic and biological systemic drugs in psoriasis: results of the BIOBADADERM registry and critical analysis

    Journal of the European Academy of Dermatology and Venereology

    Volume 30, Issue 11, November 2016, Pages: 1942–1950, P. Dávila-Seijo, E. Dauden, G. Carretero, C. Ferrandiz, F. Vanaclocha, F.-J. Gómez-García, E. Herrera-Ceballos, P. De la Cueva-Dobao, I. Belinchón, J.-L. Sánchez-Carazo, M. Alsina, J.-L. López-Estebaranz, M. Ferrán, R. Torrado, J.-M. Carrascosa, M. Llamas, R. Rivera, R. Jiménez-Puya, I. García-Doval and the BIOBADADERM Study Group

    Version of Record online : 22 JUN 2016, DOI: 10.1111/jdv.13682

  4. Risk of adverse events in psoriasis patients receiving classic systemic drugs and biologics in a 5-year observational study of clinical practice: 2008–2013 results of the Biobadaderm registry

    Journal of the European Academy of Dermatology and Venereology

    Volume 29, Issue 1, January 2015, Pages: 156–163, G. Carretero, C. Ferrandiz, E. Dauden, F. Vanaclocha Sebastián, F.J. Gómez-García, E. Herrera-Ceballos, P. De la Cueva-Dobao, I. Belinchón, J.L. Sánchez-Carazo, M. Alsina-Gibert, J.L. López-Estebaranz, M. Ferrán, R. Torrado, J.M. Carrascosa, C. Carazo, R. Rivera, R. Jiménez-Puya, I. García-Doval and the BIOBADADERM Study Group

    Version of Record online : 31 MAR 2014, DOI: 10.1111/jdv.12492

  5. Statins and Adverse Cardiovascular Events in Moderate-Risk Females: A Statistical and Legal Analysis with Implications for FDA Preemption Claims

    Journal of Empirical Legal Studies

    Volume 5, Issue 3, September 2008, Pages: 507–550, Theodore Eisenberg and Martin T. Wells

    Version of Record online : 5 SEP 2008, DOI: 10.1111/j.1740-1461.2008.00132.x

  6. Safety of classic and biologic systemic therapies for the treatment of psoriasis in elderly: an observational study from national BIOBADADERM registry

    Journal of the European Academy of Dermatology and Venereology

    Volume 29, Issue 5, May 2015, Pages: 858–864, C. Medina, G. Carretero, C. Ferrandiz, E. Dauden, F. Vanaclocha, F.J. Gómez-García, E. Herrera-Ceballos, P. De la Cueva-Dobao, I. Belinchón, J.L. Sánchez-Carazo, M. Alsina, J.L. López-Estebaranz, M. Ferrán, J.M. Carrascosa, R. Torrado, D. Argila, R. Rivera, R. Jiménez-Puya, I. García-Doval and the BIOBADADERM Study Group

    Version of Record online : 3 SEP 2014, DOI: 10.1111/jdv.12688

  7. You have full text access to this OnlineOpen article
    Psoriasis beyond the skin: an expert group consensus on the management of psoriatic arthritis and common co-morbidities in patients with moderate-to-severe psoriasis

    Journal of the European Academy of Dermatology and Venereology

    Volume 28, Issue 12, December 2014, Pages: 1661–1669, R. Strohal, B. Kirby, L. Puig and on behalf of the Psoriasis Expert Panel (G. Girolomoni, K. Kragballe, T. Luger, F.O. Nestle, J.C. Prinz, M. Ståhle, N. Yawalkar)

    Version of Record online : 24 DEC 2013, DOI: 10.1111/jdv.12350

  8. Body mass index in patients with moderate-to-severe psoriasis in Spain and its impact as an independent risk factor for therapy withdrawal: results of the Biobadaderm Registry

    Journal of the European Academy of Dermatology and Venereology

    Volume 28, Issue 7, July 2014, Pages: 907–914, J.M. Carrascosa, M. Vilavella, I. Garcia-Doval, G. Carretero, F. Vanaclocha, E. Daudén, F.J. Gómez-García, E. Herrera-Ceballos, P. De la Cueva Dobao, I. Belinchón, J.L. Sánchez-Carazo, M. Alsina, J.L. López-Estebaranz, M. Ferrán, F. Peral, R. Torrado, R. Rivera, R. Jiménez-Puya, M.V. Mendiola and C. Ferrándiz, the BIOBADADERM Study Group

    Version of Record online : 15 JUL 2013, DOI: 10.1111/jdv.12208

  9. You have full text access to this OnlineOpen article
    Long-Term Safety, Efficacy, and Quality of Life in Patients With Juvenile Idiopathic Arthritis Treated With Intravenous Abatacept for Up to Seven Years

    Arthritis & Rheumatology

    Volume 67, Issue 10, October 2015, Pages: 2759–2770, Daniel J. Lovell, Nicolino Ruperto, Richard Mouy, Eliana Paz, Nadina Rubio-Pérez, Clovis A. Silva, Carlos Abud-Mendoza, Ruben Burgos-Vargas, Valeria Gerloni, Jose A. Melo-Gomes, Claudia Saad-Magalhaes, J. Chavez-Corrales, Christian Huemer, Alan Kivitz, Francisco J. Blanco, Ivan Foeldvari, Michael Hofer, Hans-Iko Huppertz, Chantal Job Deslandre, Kirsten Minden, Marilynn Punaro, Alan J. Block, Edward H. Giannini, Alberto Martini and for the Pediatric Rheumatology Collaborative Study Group and the Paediatric Rheumatology International Trials Organisation

    Version of Record online : 23 SEP 2015, DOI: 10.1002/art.39234

  10. Recommendations for the treatment of nail psoriasis in patients with moderate to severe psoriasis: a dermatology expert group consensus

    Journal of the European Academy of Dermatology and Venereology

    Volume 26, Issue 3, March 2012, Pages: 373–381, R.G. Langley, J.H. Saurat, K. Reich and on behalf of the Nail Psoriasis Delphi Expert Panel

    Version of Record online : 10 DEC 2011, DOI: 10.1111/j.1468-3083.2011.04349.x

  11. Effects of voluntary dose escalation in a placebo-controlled, flexible-dose trial of fesoterodine in subjects with overactive bladder

    Neurourology and Urodynamics

    Volume 30, Issue 8, November 2011, Pages: 1480–1485, David Staskin, Vik Khullar, Martin C. Michel, Jon D. Morrow, Franklin Sun, Zhonghong Guan and Roger Dmochowski

    Version of Record online : 10 MAY 2011, DOI: 10.1002/nau.21099

  12. Predictors of adalimumab drug survival in psoriasis differ by reason for discontinuation: long-term results from the Bio-CAPTURE registry

    Journal of the European Academy of Dermatology and Venereology

    Volume 29, Issue 3, March 2015, Pages: 560–565, J.M.P.A. van den Reek, M. Tummers, J. Zweegers, M.M.B. Seyger, P.P.M. van Lümig, R.J.B. Driessen, P.C.M. van de Kerkhof, W. Kievit and E.M.G.J. de Jong

    Version of Record online : 3 AUG 2014, DOI: 10.1111/jdv.12636

  13. Applying Precaution in EU Authorisation of Genetically Modified Products—Challenges and Suggestions for Reform

    European Law Journal

    Volume 16, Issue 5, September 2010, Pages: 624–657, Maria Weimer

    Version of Record online : 23 AUG 2010, DOI: 10.1111/j.1468-0386.2010.00526.x

  14. The correlation of clinical efficacy, serum trough levels and antidrug antibodies in ustekinumab-treated patients with psoriasis in a clinical-practice setting

    British Journal of Dermatology

    Volume 173, Issue 3, September 2015, Pages: 855–857, S.P. Menting, J.M.P.A. van den Reek, E.M. Baerveldt, E.M.G.J. de Jong, E.P. Prens, L.L.A. Lecluse, G.J. Wolbink, D. Van der Kleij, Ph.I. Spuls and T. Rispens

    Version of Record online : 2 AUG 2015, DOI: 10.1111/bjd.13834

  15. Rapid identification of somatic mutations in colorectal and breast cancer tissues using mismatch repair detection (MRD)

    Human Mutation

    Volume 29, Issue 3, March 2008, Pages: 441–450, Steven Bentivegna, Jianbiao Zheng, Eugeni Namsaraev, Victoria E.H. Carlton, Adam Pavlicek, Martin Moorhead, Farooq Siddiqui, Zhiyong Wang, Liana Lee, James S. Ireland, Kent Suyenaga, Thomas D. Willis, Malek Faham and Albert B. Seymour

    Version of Record online : 10 JAN 2008, DOI: 10.1002/humu.20672

  16. You have free access to this content
    The Concept of Axial Spondyloarthritis: Joint Statement of the Spondyloarthritis Research and Treatment Network and the Assessment of SpondyloArthritis international Society in Response to the US Food and Drug Administration's Comments and Concerns

    Arthritis & Rheumatology

    Volume 66, Issue 10, October 2014, Pages: 2649–2656, Atul Deodhar, John D. Reveille, Filip van den Bosch, Jürgen Braun, Ruben Burgos-Vargas, Liron Caplan, Daniel O. Clegg, Robert A. Colbert, Lianne S. Gensler, Désirée van der Heijde, Irene E. van der Horst-Bruinsma, Robert D. Inman, Walter P. Maksymowych, Philip J. Mease, Siba Raychaudhuri, Andreas Reimold, Martin Rudwaleit, Joachim Sieper, Michael H. Weisman and Robert B. M. Landewé

    Version of Record online : 26 SEP 2014, DOI: 10.1002/art.38776

  17. Clinical and Genetic Features of Patients With TNFRSF1A Variants in Japan: Findings of a Nationwide Survey

    Arthritis & Rheumatology

    Volume 68, Issue 11, November 2016, Pages: 2760–2771, Naoyasu Ueda, Hiroaki Ida, Masakazu Washio, Hisaaki Miyahara, Shoji Tokunaga, Fumiko Tanaka, Hiroki Takahashi, Koichi Kusuhara, Koichiro Ohmura, Manabu Nakayama, Osamu Ohara, Ryuta Nishikomori, Seiji Minota, Shuji Takei, Takao Fujii, Yoshiaki Ishigatsubo, Hiroshi Tsukamoto, Tomoko Tahira and Takahiko Horiuchi

    Version of Record online : 27 OCT 2016, DOI: 10.1002/art.39793

  18. You have free access to this content
    Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis

    Arthritis & Rheumatology

    Volume 68, Issue 5, May 2016, Pages: 1060–1071, Laura C. Coates, Arthur Kavanaugh, Philip J. Mease, Enrique R. Soriano, Maria Laura Acosta-Felquer, April W. Armstrong, Wilson Bautista-Molano, Wolf-Henning Boehncke, Willemina Campbell, Alberto Cauli, Luis R. Espinoza, Oliver FitzGerald, Dafna D. Gladman, Alice Gottlieb, Philip S. Helliwell, M. Elaine Husni, Thorvardur J. Love, Ennio Lubrano, Neil McHugh, Peter Nash, Alexis Ogdie, Ana-Maria Orbai, Andrew Parkinson, Denis O'Sullivan, Cheryl F. Rosen, Sergio Schwartzman, Evan L. Siegel, Sergio Toloza, William Tuong and Christopher T. Ritchlin

    Version of Record online : 23 MAR 2016, DOI: 10.1002/art.39573

  19. UNDERSTANDING INFORMED CONSENT FOR PARTICIPATION IN INTERNATIONAL HEALTH RESEARCH

    Developing World Bioethics

    Volume 9, Issue 2, August 2009, Pages: 81–87, AYODELE S. JEGEDE

    Version of Record online : 15 JUL 2008, DOI: 10.1111/j.1471-8847.2008.00238.x

  20. Factors associated with the choice of the first biologic in psoriasis: real-life analysis from the Psobioteq cohort

    Journal of the European Academy of Dermatology and Venereology

    E. Sbidian, C. Giboin, H. Bachelez, C. Paul, M. Beylot-Barry, A. Dupuy, M. Viguier, J.-P. Lacour, J.-L. Schmutz, P. Bravard, E. Mahé, N. Beneton, L. Misery, E. Delaporte, P. Modiano, S. Barbarot, E. Regnier, D. Jullien, M.-A. Richard, P. Joly, F. Tubach and O. Chosidow

    Version of Record online : 16 JUL 2017, DOI: 10.1111/jdv.14406